Breathing better, sleeping deeper? new trial tests rehab for COPD sleep troubles
NCT ID NCT06677268
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a respiratory rehabilitation program (exercise and education sessions over 8 weeks) can improve sleep quality in people with stable COPD. 90 adults aged 50 and older will be randomly assigned to either the rehab program or usual care. Sleep will be measured using overnight sleep studies (polysomnography) and questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- respiratory rehabilitation program (exercise sessions and educational workshops)
- What this could lead to
- If it works, this could show that respiratory rehabilitation improves sleep quality in people with stable COPD.
- What could go wrong
- This is a small, early-stage trial with only 90 participants. The results may not apply to all COPD patients, and sleep improvements might be modest or not occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Feb 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female ≥ age 50 * COPD defined according to the GOLD 2022 criteria, clinically stable (without exacerbation for at least 4 weeks), with indication for respiratory rehabilitation * Absence of respiratory rehabilitation in the past 12 months * Patient affiliated to the social security system * For women of childbearing potential who have been on effective contraception (estrogen-progestogen or intrauterine device or tubal ligation) for 1 month. * For postmenopausal women: confirmatory diagnosis (non-medically induced amenorrhea for at least 12 months prior to the inclusion visit) * Patient who has read and understood the information letter and signed the consent form Exclusion Criteria: * BMI≥ 30 kg/m2 * Previously documented OSA (AHI \> 10/h) * Patient with a CPAP or NIV * Patient on systemic corticosteroid therapy * Patient on centrally acting therapy (benzodiazepine or opiate) * Patient with an occurrence of severe COPD exacerbation * Patient with other associated chronic respiratory insufficiency * Patient with active cancer * Patient with neuromuscular disease * Patient with an osteoarticular disability or traumatic or neurological sequelae preventing participation in the respiratory rehabilitation program * Psychiatric, cognitive or linguistic disorders with inability to understand to follow the protocol * Patient with a contraindication to respiratory rehabilitation or any pathology preventing physical rehabilitation * Patient with a cardiovascular contraindication to respiratory rehabilitation * Person deprived of liberty by an administrative or judicial decision or person placed under judicial safeguard, guardianship or curatorship * Person subject to a legal protection measure * Pregnant or parturient or breastfeeding woman
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (chronic obstructive pulmonary disease) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre de Sante Adir
NOT_YET_RECRUITINGRouen, 76000, France
-
Chu Amiens
NOT_YET_RECRUITINGAmiens, 80054, France
-
Chu Rouen
RECRUITINGRouen, 76031, France
-
Gh Le Havre
NOT_YET_RECRUITINGLe Havre, 76083, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Patient's own airway stem cells repair damaged lungs in COPD?
- Six biologics put to the test in Real-World asthma and COPD care
- Can a breathing routine ease COPD breathlessness?
- Switching to a nebulizer may help COPD patients who get no relief from inhalers
- Can extra oxygen during rehab change how COPD patients breathe?
- AI chest X-Rays could catch hidden lung disease in zambia